Noticias del mercado de valores

Últimas noticias financieras · Actualizado Jun 24, 2026

AIR
▬ mixed

Factbox-Las aerolíneas cancelan vuelos en respuesta al conflicto de Oriente Medio

Factbox-Airlines cancel flights in response to Middle East conflict

The panel consensus is that the flight cancellations and rerouting represent a significant, potentially permanent, shift in regional logistics and …

Yahoo Finance · May 07, 2026
EHTH ET Q
▬ mixed

eHealth (EHTH) transcripción de las ganancias del primer trimestre de 2026

eHealth (EHTH) Q1 2026 Earnings Transcript

The panel is divided on eHealth's pivot to a lifetime advisory model. While some see improved LTV/CAC ratios and cost …

Yahoo Finance · May 07, 2026
META
▬ mixed

Pivotal Research Mantiene una Postura Alcista sobre Meta Platforms (META) Pero Recorta el PT

Pivotal Research Remains Bullish on Meta Platforms (META) But Cuts PT

The panel's net takeaway is that Meta's (META) impressive 33% YoY revenue growth is being scrutinized due to uncertainty around …

Yahoo Finance · May 07, 2026
MSFT
▬ mixed

Esto es lo que Wall Street piensa sobre Microsoft Corporation (MSFT) después de sus resultados

Here’s What the Street Thinks About Microsoft Corporation (MSFT) Post Earnings

Analysts have mixed views on MSFT's AI execution and future margins. While Azure's growth is impressive, the $190B FY26 capex …

Yahoo Finance · May 07, 2026
NVDA
▬ mixed

¿Puede Nvidia Alcanzar los $300 para 2027? Aquí le Explicamos Por Qué la Respuesta Es Sí

Can Nvidia Hit $300 by 2027? Here’s Why the Answer Is Yes

Panelists agree that Nvidia's FY2026 results are impressive, but the $300 target price hinges on sustained AI spend and successful …

Yahoo Finance · May 07, 2026
BMRN Z
▬ mixed

¿Es BioMarin Pharmaceutical Inc. (BMRN) una de las principales acciones baratas para comprar con el mayor potencial de crecimiento?

Is BioMarin Pharmaceutical Inc. (BMRN) One of the Top Cheap Stocks to Buy With the Biggest Upside Potential?

The panel's discussion revolves around BioMarin's (BMRN) potential and valuation, with a focus on VOXZOGO's clinical data and the company's …

Yahoo Finance · May 07, 2026
CDE S U
▬ mixed

Canaccord Sube Coeur Mining (CDE) por Factores que Impulsan el Oro

Canaccord Upgrades Coeur Mining (CDE) on Factors Driving Gold

The panel's net takeaway is that Coeur Mining's (CDE) valuation relies heavily on a bullish gold price projection and operational …

Yahoo Finance · May 07, 2026
EPAM
▬ mixed

Guggenheim Recorta PT de EPAM Systems (EPAM) en Medio de Riesgos para las Perspectivas de Ingresos del Q2

Guggenheim Cuts PT on EPAM Systems (EPAM) Amid Risks to Q2 Revenue Outlook

EPAM's 'quality vendor' status is being challenged due to potential margin compression in Q2, driven by a 'softer demand environment' …

Yahoo Finance · May 07, 2026
▬ mixed

Por qué el Mayor Ganador del Auge de la Infraestructura de IA No Es Quien Cree Wall Street

Why the Biggest Winner of the AI Infrastructure Boom Isn't Who Wall Street Thinks

While Dell's AI revenue growth and backlog are promising, the panelists have significant concerns about the sustainability of margins, potential …

Nasdaq · May 07, 2026
BIRK
▬ mixed

Deutsche Bank Recorta PT de Birkenstock Holding (BIRK) Como Parte de la Vista Previa del Q2

Deutsche Bank Cuts PT on Birkenstock Holding (BIRK) As Part of Q2 Preview

The panel is divided on Birkenstock's outlook, with concerns about inventory levels, geopolitical risks, and currency volatility offsetting optimism about …

Yahoo Finance · May 07, 2026
BR SA
▬ mixed

Beneficio del Groupe Bruxelles Lambert en el primer trimestre cae un 31% ante la disminución del NAV

Groupe Bruxelles Lambert Q1 Profit Falls 31% As NAV Declines

GBL's Q1 results show a complex picture with cash earnings up 21% but NAV down 14%. The company is pivoting …

Nasdaq · May 07, 2026
META
▬ mixed

El camino de Meta hacia los $1000 depende de una gran pregunta

Meta's Path to $1000 Depends on One Massive Question

The panel is divided on Meta's path to $1000 share price, with concerns about AI capex, regulatory risks, and competition, …

Nasdaq · May 07, 2026